Melissa Aldinger
Impact in
-
- Hematopoietic Stem Cell Transplantation
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
- Oncology 4
- Polyomavirus and related diseases 2
- CAR-T cell therapy research 2
- Co-authors
- Andrew Skingsley (5 shared papers)Amanda Peppercorn (5 shared papers)Franco Locatelli (4 shared papers)Chengjie Xiong (1 shared paper)Randall J. Bateman (1 shared paper)Andrea L. Cathcart (3 shared papers)David M. Holtzman (1 shared paper)Erik S. Musiek (1 shared paper)
- Journals
- Blood (4 papers)Open Forum Infectious Diseases (2 papers)JAMA Neurology (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Melissa Aldinger
10 papers receiving 45 citations
Melissa Aldinger's Hit Papers
Peers
Comparison fields: 5 of 24
- Hematology 8
- Infectious Diseases 11
- Immunology 6
- Emergency Medicine 2
- Psychiatry and Mental health 3
Countries citing papers authored by Melissa Aldinger
This map shows the geographic impact of Melissa Aldinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Aldinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Aldinger more than expected).
Fields of papers citing papers by Melissa Aldinger
This network shows the impact of papers produced by Melissa Aldinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Aldinger. The network helps show where Melissa Aldinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Aldinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lecanemab Treatment in a Specialty Memory Clinic Hit paper breakdown → | 2025 | 24 |
| 2 | 2023 | 5 | |
| 3 | 2018 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 3 | |
| 6 | 2019 | 2 | |
| 7 | 2023 | 2 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2024 | 0 | |
| 12 | 2024 | 0 |
About Melissa Aldinger
Melissa Aldinger is a scholar working on Infectious Diseases, Oncology, Molecular Biology, Hematology and Epidemiology, having authored 12 papers that have together received 47 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Polyomavirus and related diseases (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), CAR-T cell therapy research (2 papers), CRISPR and Genetic Engineering (2 papers), Acute Myeloid Leukemia Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Hematology (8 citations), Infectious Diseases (11 citations), Immunology (6 citations), Emergency Medicine (2 citations) and Psychiatry and Mental health (3 citations). Melissa Aldinger has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Andrew Skingsley, Amanda Peppercorn, Franco Locatelli, Chengjie Xiong, Randall J. Bateman, Andrea L. Cathcart, David M. Holtzman, Erik S. Musiek, Tammie L.S. Benzinger and Elizabeth Alexander. Their work appears in journals such as Blood, Open Forum Infectious Diseases, JAMA Neurology, CPT Pharmacometrics & Systems Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.